Does continued alendronate therapy improve bone mineral density and reduce fracture risk in postmenopausal women?

被引：2
|
作者：
Kraenzlin, Marius E. [1 ]
Meier, Christian [1 ]
机构：
[1] Univ Basel Hosp, Div Endocrinol Diabet Clin Nutr, CH-4055 Basel, Switzerland
来源：
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM | 2007年 / 3卷 / 10期
关键词：
alendronate; BMD; bone turnover; nonvertebral fracture; vertebral fracture;
D O I：
10.1038/ncpendmet0618
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：686 / 687
页数：2
相关论文
共 50 条
  • [21] Combination therapy of curcumin an alendronate modulates bone turnover markers and enhances bone mineral density in postmenopausal women with osteoporosis
    Khanizadeh, Fatemeh
    Rahmani, Asghar
    Asadollahi, Khairollah
    Ahmadi, Mohammad Reza Hafezi
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2018, 62 (04): : 438 - 445
  • [22] Effect of Abaloparatide on Fracture Incidence and Bone Mineral Density in Postmenopausal Women with Osteoporosis at Highest Risk for Fracture
    Clarke, Bart
    Kostenuik, Paul
    Wang, Yamei
    Tough-DeSapri, Kristi
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2021, 28 (12): : 1448 - 1448
  • [23] Effects of raloxifene and alendronate on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis
    Johnell, O
    Lu, Y
    Seeman, E
    Reginster, J
    Scheele, W
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S184 - S184
  • [24] Does alendronate improve bone mineral density in patients with RA treated with glucocorticoids?
    Lane, Nancy E.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (08): : 412 - 413
  • [25] Does alendronate improve bone mineral density in patients with RA treated with glucocorticoids?
    Nancy E Lane
    Nature Clinical Practice Rheumatology, 2006, 2 : 412 - 413
  • [26] Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis
    Hochberg, MC
    Ross, PD
    Black, D
    Cummings, SR
    Genant, HK
    Nevitt, MC
    Barret-Connor, E
    Musliner, T
    Thompson, D
    ARTHRITIS AND RHEUMATISM, 1999, 42 (06): : 1246 - 1254
  • [27] Impact of bone mineral density in reducing fracture risk in patients receiving alendronate plus alfacalcidol therapy
    Itoi, Eiji
    Uemura, Yukari
    Ohta, Hiroaki
    Nakamura, Toshitaka
    Fukunaga, Masao
    Orimo, Hajime
    Shiraki, Masataka
    JOURNAL OF ORTHOPAEDIC SCIENCE, 2021, 26 (06) : 1085 - 1093
  • [28] Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis
    Watts, N. B.
    Hattersley, G.
    Fitzpatrick, L. A.
    Wang, Y.
    Williams, G. C.
    Miller, P. D.
    Cosman, F.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 (06) : 1187 - 1194
  • [29] Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis
    N.B. Watts
    G. Hattersley
    L.A. Fitzpatrick
    Y. Wang
    G.C. Williams
    P.D. Miller
    F. Cosman
    Osteoporosis International, 2019, 30 : 1187 - 1194
  • [30] Forearm Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis
    Watts, Nelson B.
    Dore, Robin K.
    Baim, Sanford
    Hattersley, Gary
    Williamss, Greg
    Wang, Yamei
    Rozental, Tamara D.
    LeBoff, Meryl S.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345